Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2005-08-02
2005-08-02
Wessendorf, T.D. (Department: 1639)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S184100, C514S014800, C514S023000, C530S327000, C530S300000
Reexamination Certificate
active
06923965
ABSTRACT:
The present invention provides peptides with a specific affinity for glycosaminoglycan molecules. These peptides may have any number of functions, including but not limited to use as inhibitors of glycosaminoglycan-mediated processes, enhancers of glycosaminoglycan-mediated processes, and as molecular probes to identify the presence of a specific glycosaminoglycan. Peptides of the invention may be directed against any glycosaminoglycan, including hyaluronic acid, chondroitin sulfate A, chondroitin sulfate C, dermatan sulfate, heparin, keratan sulfate, keratosulfate, chitin, chitosan 1, and chitosan 2. These isolated peptides may have therapeutic uses in the treatment or prevention of diseases involving infection, inflammatory diseases, cancer, infections, etc. The peptides may also have other biological functions such as contraception.
REFERENCES:
patent: 5981478 (1999-11-01), Ruoslahti et al.
patent: 0950708 (1999-10-01), None
patent: WO 93/21312 (1993-10-01), None
patent: WO 02/28415 (2002-04-01), None
Henri Becquerel, Role of hyaluronic acid in the arterial response to angioplasty, 1998, J. Path. Biol. 46: 561-570.
Van Kuppelt et al., (1998),J. Biol. Chem.,273(21):12960-12966.
Liang et al., (1997),FEBS.,407:169-172.
Kubens et al., (1997),Cancer Lett.,118:189-200.
Barbas et sl. (1992) “Semisynthetic combinatorial antibody libraries: A chemical solution to the diversity problem.”Proc. Natl. Acad. Sci. USA,vol. 89:4457-4461.
Garrard et al. (1993) “Selection of an anti-IGF-1 Fab from a Fab phage library created by mutagenesis of multiple CDR loops.”Gene,vol. 128:103-109.
Dougherty et al. (Mar. 25, 1994), “Ligand Binding Specificity of Alternatively Spliced CD44 Isoforms-Recognition and Binding of Hyaluronan by CD44R1.”The Journal of Biological Chemistry,vol. 269(12):9074-9078.
Levesque et al. (1996), “In Vitro Culture of Human Peripheral Blood Monocytes Induces Hyaluronan Binding and Up-Regulates Monocyte Variant CD44 Isoform Expression.”The Journal of Immunology,vol. 156:1557-1565.
Steinman, Ralph (1991), “The Dendritic Cell System and its Role in Immunogenicity.”Ann. Rev. Immunol.,vol. 9:271-296.
Turley et al. (Mar. 1991), “Hyaluronan and a Cell-associated Hyaluronan Binding Protein Regulate the Locomotion of Ras-transformed Cells.”The Journal of Cell Biology,vol. 112(5):1041-1047.
Mohamadzadeh Mansour
Mummert Mark E.
Takashima Akira
Bozicevic Field & Francis LLP
Keddie James S.
The University of Texas System
Wessendorf T.D.
LandOfFree
Modulators of polysaccharides and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulators of polysaccharides and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulators of polysaccharides and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3517982